Cancers Data Trials Drugs Genes Biomarkers Approvals Rankings Research gap Graph

Pulse Data updates Year in cancer Taxonomy Countries Compare Trial intelligence Trial map Drug pipeline Sources Methodology About Trust & policies Data downloads Developers (API)

Loading cancer entity…

CancerIndex

CancerIndex is a research and information platform. It is not a physician, does not diagnose, and does not recommend treatment. Population statistics do not predict individual outcomes.

Every number links to its source and retrieval date. Derived metrics carry a formula version. AI-generated synthesis is not enabled in this phase; all content is database-grounded.

About Trust & policies Data explorer Data downloads Pulse Data update log Developers (API)Sources Methodology Taxonomy Countries Compare Contact · contact@spboucher.ai Status

© 2026 CancerIndex · built and maintained by Simon-Pierre Boucher · contact contact@spboucher.ai · hosted on MacLustr (www.maclustr.io). Source data remains under the license of each provider — see /sources.

Paraganglioma — Trials · CancerIndex

Cancers
Neoplasm
Neoplasm by Site
Endocrine Neoplasm
Neuroendocrine Neoplasm
Paraganglioma

Subtype

Paraganglioma

CI-CAN-00001374Explore in graph →

Non-malignant30 active trials3 evidence items

NCIt: C3308
OncoTree: PGNG
DOID: 0050773
UMLS CUI: C0030421
MeSH: D010235
Other: 1 more code

Overview
Statistics
Survival
Genomics1
Variants & evidence3
Drugs
Trials144
Research
Rankings
Sources & provenance

Clinical trials

Registered studies

144 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

StatusAll Active (any)Completed 55 Recruiting 26 Unknown 17 Terminated 11 Active Not Recruiting 11 Not Yet Recruiting 9 Withdrawn 6 No Longer Available 3 Available 3 Approved For Marketing 2 Enrolling By Invitation 1

PhaseAll Early Phase 1 3 N/A 13 Phase 1 20 Phase 2 49 Phase 3 5 Phase 4 5

No study matches these filters